Aims To develop prediction models for identifying cases with poor visual outcomes after surgery for primary rhegmatogenous ...

Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some and turning deadly disease into a manageable chronic condition in others.

A large study applies advanced machine learning to identify shared risk factors and predictors of disease onset in patients with epilepsy and depression.

After a decade of cognitive and functional decline, an 80-year-old patient with advanced Alzheimer’s disease showed remarkable signs of progress. All it took was a single dose of an experimental ...

Effective risk stratification in cancer survivorship requires handling longitudinal data characterized by multimodal inputs, irregular follow-up, and recurrent clinical events. This study evaluated ...

Two patients developed choroidal lymphoid hyperplasia associated with vision loss after starting treatment with the GLP-1 receptor agonist dulaglutide. Visual acuity and systemic lymphadenopathy ...

Follow this author to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Blonde woman laying on bed Personalized Content Follow this author to ...

Months after revealing his stage 4 cancer diagnosis, former U.S. Sen. Ben Sasse is speaking out about an experimental therapy that could extend his life. Sasse, a Republican who represented Nebraska ...

WASHINGTON (AP) — The Food and Drug Administration said Friday it will offer ultra-fast review to three psychedelic drugs being developed to treat mental health conditions, including depression, the ...

A 7-year-old girl is clinging to life after police say she was exposed to a combination of powerful drugs. According to St. Ann Police Department Capt. Blake Carrigan, the girl is listed in critical ...

FDA Commissioner Marty Makary said the agency will soon issue priority review vouchers to three serotonin 2a agonists. President Donald Trump has ordered the FDA to perform priority reviews of ...